β-hCG resolution times during expectant management of tubal ectopic pregnancies
BMC Women's Health, ISSN: 1472-6874, Vol: 15, Issue: 1, Page: 43
2015
- 14Citations
- 38Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations14
- Citation Indexes14
- 14
- CrossRef4
- Captures38
- Readers38
- 38
Article Description
Background: A subset of women with a tubal ectopic pregnancy can be safely managed expectantly. Expectant management involves a degree of disruption with hospital visits to determine serum β-hCG (β-human chorionic gonadotrophin) concentration until the pregnancy test becomes negative and expectant management is considered complete. The length of time required for the pregnancy test to become negative and the parameters that influence this interval have not been described. Information on the likely length of follow up would be useful for women considering expectant management of their tubal ectopic pregnancy. Methods: This was a retrospective study at a tertiary referral center in an inner city London Hospital. We included women who were diagnosed with a tubal ectopic pregnancy by transvaginal ultrasound between March 2009 and March 2014. During the study period 474 women were diagnosed with a tubal ectopic pregnancy and 256 (54 %) of them fulfilled our management criteria for expectant management. A total of 158 (33 %) women had successful expectant management and in those cases we recorded the diameter of the ectopic pregnancy (mm), the maximum serum β-hCG (IU/L) and levels during follow up until resolution as well as the interval to resolution (days). Results: The median interval from maximum serum β-hCG concentration to resolution was 18.0 days (IQR 11.0-28.0). The maximum serum β-hCG concentration and the rate of decline of β-hCG were independently associated with the length of follow up. Women's age and size of ectopic pregnancy did not have significant effects on the length of follow up. Conclusion: Women undergoing expectant management of ectopic pregnancy can be informed that the likely length of follow up is under 3 weeks and that it positively correlates with initial β-hCG level at the time of diagnosis.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84930208161&origin=inward; http://dx.doi.org/10.1186/s12905-015-0200-7; http://www.ncbi.nlm.nih.gov/pubmed/25994203; https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-015-0200-7; https://dx.doi.org/10.1186/s12905-015-0200-7; http://www.biomedcentral.com/1472-6874/15/43; https://bmcwomenshealth.biomedcentral.com/counter/pdf/10.1186/s12905-015-0200-7; http://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-015-0200-7; http://link.springer.com/article/10.1186/s12905-015-0200-7/fulltext.html; https://link.springer.com/track/pdf/10.1186/s12905-015-0200-7; https://link.springer.com/articles/10.1186/s12905-015-0200-7; https://link.springer.com/article/10.1186/s12905-015-0200-7
Springer Nature
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know